Q1 2015

Source filing unavailable

Q1 2015 · —

Revenue

$11.66M

no prior Q1 2014 on file

Net Income

-$11.02M

no prior Q1 2014 on file

EPS Diluted

-$0.54

no prior Q1 2014 on file

Operating Income-$11,102,000—

Margins · derived

Operating margin-95.2%

Net margin-94.5%

Same quarter

no prior Q1 2014 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Aptevo Therapeutics Inc. · CIK 1671584 · Engraved from SEC EDGAR